Literature DB >> 26146359

Deciphering the binding patterns and conformation changes upon the bovine serum albumin-rosmarinic acid complex.

Xin Peng1, Xiangchao Wang, Wei Qi, Renliang Huang, Rongxin Su, Zhimin He.   

Abstract

Rosmarinic acid (RA) is an importantly and naturally occurring polyphenol from plants of the mint family with potent biological activities. Here, the in vitro interaction of RA with bovine serum albumin (BSA) has been investigated using various biophysical approaches as well as molecular modeling methods, to ascertain its binding mechanism and conformational changes. The fluorescence results demonstrated that the fluorescence quenching of BSA by RA was mainly the result of the formation of a ground state BSA-RA complex, and BSA had one high affinity RA binding site with a binding constant of 4.18 × 10(4) mol L(-1) at 298 K. Analysis of thermodynamic parameters revealed that hydrophobic and hydrogen bond interactions were the dominant intermolecular force in the complex formation. The primary binding site of RA in BSA (site I) had been identified by site marker competitive experiments. The distance between RA and the tryptophan residue of BSA was evaluated at 3.12 nm based on Förster's theory of non-radiation energy transfer. The UV-vis absorption, synchronous fluorescence, three-dimensional fluorescence, 8-anilino-1-naphthalenesulfonic acid (ANS) fluorescence, circular dichroism (CD), and Fourier transform infrared (FT-IR) spectra confirmed that the conformation and structure of BSA were altered in the presence of RA. Moreover, the nuclear magnetic spectroscopy showed that the aromatic groups of RA took part in the binding reaction during the BSA-RA complexation. In addition, the molecular picture of the interaction mechanism between BSA and RA at the atomic level was well examined by molecular docking and dynamics studies. In brief, RA can bind to BSA with noncovalent bonds in a relatively stable way, and these findings will be beneficial to the functional food research of RA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26146359     DOI: 10.1039/c5fo00597c

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  6 in total

1.  A Comprehensive Investigation of Interactions between Antipsychotic Drug Quetiapine and Human Serum Albumin Using Multi-Spectroscopic, Biochemical, and Molecular Modeling Approaches.

Authors:  Seema Zargar; Tanveer A Wani; Nawaf A Alsaif; Arwa Ishaq A Khayyat
Journal:  Molecules       Date:  2022-04-18       Impact factor: 4.927

2.  Study of Interactions of an Anticancer Drug Neratinib With Bovine Serum Albumin: Spectroscopic and Molecular Docking Approach.

Authors:  Tanveer A Wani; Ahmed H Bakheit; M A Abounassif; Seema Zargar
Journal:  Front Chem       Date:  2018-03-07       Impact factor: 5.221

3.  Interaction study of monoisoamyl dimercaptosuccinic acid with bovine serum albumin using biophysical and molecular docking approaches.

Authors:  Ashima Thakur; Jayant Patwa; Suyash Pant; Abha Sharma; S J S Flora
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

4.  New insights into the competition between antioxidant activities and pro-oxidant risks of rosmarinic acid.

Authors:  Dinh Hieu Truong; Thi Chinh Ngo; Nguyen Thi Ai Nhung; Duong Tuan Quang; Thi Le Anh Nguyen; Dorra Khiri; Sonia Taamalli; Florent Louis; Abderrahman El Bakali; Duy Quang Dao
Journal:  RSC Adv       Date:  2022-01-10       Impact factor: 3.361

5.  Effect of Ling-Gui-Zhu-Gan decoction major components on the plasma protein binding of metoprolol using UPLC analysis coupled with ultrafiltration.

Authors:  Peng Zhou; Jinling Huang; Wanxue Ding
Journal:  RSC Adv       Date:  2018-10-22       Impact factor: 4.036

6.  Unveiling the interaction profile of rosmarinic acid and its bioactive substructures with serum albumin.

Authors:  Christina Papaemmanouil; Maria V Chatziathanasiadou; Christos Chatzigiannis; Eleni Chontzopoulou; Thomas Mavromoustakos; Simona Golic Grdadolnik; Andreas G Tzakos
Journal:  J Enzyme Inhib Med Chem       Date:  2020-12       Impact factor: 5.051

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.